Back
Guidewire Software Vs. Blueprint Medicines Industry Stock Comparison
Buy
70
GWRE
Guidewire Software
Last Price:
$230.34
Seasonality Move:
6.69%
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.39
Seasonality Move:
6.28%
Buy
70
Guidewire Software (GWRE)
is a Buy
Is Guidewire Software a Buy, Sell or Hold?
-
The current Guidewire Software [GWRE] share price is $230.38. The Score for GWRE is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
GWRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GWRE Stock Price Chart
What is Guidewire Software's stock price today?
-
The Guidewire Software share price today is $230.38The current trend is moderately bearish and GWRE is experiencing slight buying pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
GWRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.52 | Buy |
Relative Strength Index (14 RSI): | 45.69 | Sell |
Chaikin Money Flow: | 26007 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (225.47 - 253.15) | Sell |
Bollinger Bands (100): | (187.75 - 231.07) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.65 | Buy |
Relative Strength Index (14 RSI): | 74.59 | Buy |
Chaikin Money Flow: | 675123 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119 - 133.06) | Buy |
Bollinger Bands (100): | (84.56 - 117) | Buy |
GWRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 233.57 | Sell |
20-day SMA: | 243.45 | Sell |
50-day SMA: | 224.24 | Buy |
200-day SMA: | 197.56 | Buy |
8-day EMA: | 233.68 | Sell |
20-day EMA: | 235.32 | Sell |
50-day EMA: | 225.76 | Buy |
200-day EMA: | 195.4 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.23 | Buy |
20-day SMA: | 128.14 | Buy |
50-day SMA: | 111.57 | Buy |
200-day SMA: | 97.6 | Buy |
8-day EMA: | 128.16 | Buy |
20-day EMA: | 125.23 | Buy |
50-day EMA: | 115.07 | Buy |
200-day EMA: | 100.77 | Buy |
Guidewire Software Earnings Growth & GWRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.16 per share, an increase this year of $1.12 per share, and an increase next year of $0.39 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Guidewire Software Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |